Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial)
Clinical trial NCT04832880 · UNKNOWN
Trial details
- NCT number
- NCT04832880
- Sponsor
- ASST Fatebenefratelli Sacco
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-04-06
- Primary completion
- 2022-03-01
- Enrollment
- 4000
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.